logo

Gilead Sciences Inc. (GILD)



Trade GILD now with
  Date
  Headline
6/28/2022 6:03:09 AM Kite: EC Approves CAR T-cell Therapy Yescarta For Relapsed Or Refractory Follicular Lymphoma
6/24/2022 8:03:32 AM Gilead : Investigational Lenacapavir Receives Positive CHMP Opinion For People With Multi-Drug Resistant HIV
6/23/2022 8:34:18 AM GILD:Treatment With Hepcludex Meets Primary Endpoint And Achieves Significant Response In Chronic Hepatitis Delta Virus
6/6/2022 9:05:17 AM GILD : Phase 3 Study Shows Trodelvy Extends Overall Survival Over Chemotherapy In Second-Line Metastatic TNBC
6/2/2022 9:07:44 AM Gilead Sciences Appoints Stacey Ma As EVP, Pharmaceutical Development And Manufacturing
5/2/2022 8:34:06 AM Gilead And Dragonfly Announce Strategic Research Collaboration
4/28/2022 4:29:05 PM Gilead Sciences Q1 EPS $0.02 Vs. $1.37 Year Ago
4/19/2022 8:08:00 AM Kite: FDA Approves Commercial Production At New CAR T-cell Therapy Manufacturing Facility In Frederick, Maryland
3/28/2022 11:10:18 AM Gilead Sciences Announces $24 Mln In Grants To Help End HIV Epidemic